Fradiomycin
Fradiomycin or neomycin, an aminoglycoside antibiotic, is first isolated in 1949 from the gram-positive bacillus Streptomyces fradiae. It consists of a mixture of two isomers, fradiomycin B and fradiomycin C. Fradiomycin has broad activity against Gram-negative bacteria except Pseudomonas aeruginosa and Gram-positive bacteria. It binds with bacterium ribosome 30s, and then it inhibits bacterial growth by inhibiting protein synthesis.
Product Specifications
CAS Number
1404-04-2
Purity
>98% (HPLC)
Smiles
O[C@H]1[C@H] (O) [C@@H] (N) [C@@H] (O[C@@H]2[C@@H] (N) C[C@@H] (N) [C@H] (O) [C@H]2O[C@@H]3O[C@H] (CO) [C@@H] (O[C@H]4O[C@@H] (CN) [C@@H] (O) [C@H] (O) [C@H]4N) [C@H]3O) O[C@@H]1CN
Molecular Formula
C23H46N6O13
Molecular Weight
614.64
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2062-100 1x 100 µL
TLE1 (Synovial Sarcoma Marker) (TLE1/2062), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-D438950-50MG 50 mg
6,7-Dichloro-1-ethyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester
Sign In for Pricing
View Details 
